Kuwait – To help residents all through the month of Ramadan and past in managing their diabetes, AstraZeneca Kuwait at this time introduced a brand new public consciousness marketing campaign scheduled to kick off within the holy month, titled ‘Past Sugar’. The marketing campaign is in partnership with the Kuwait Diabetes Society, Kuwait Nephrology Affiliation, Kuwait Society of Endocrinology, and the Kuwait Medical Affiliation and goals to extend consciousness concerning the problems and administration of Sort 2 Diabetes Mellitus (T2DM).
Diabetes impacts thousands and thousands of individuals every year internationally and roughly 22% of Kuwait’s inhabitants. Kuwait ranks among the many prime 20 nations worldwide within the prevalence of diabetes, and virtually 50% of the nation’s diabetic inhabitants stays undiagnosed. The marketing campaign goals to coach the general public on T2DM to make sure higher well being administration and protected fasting in Ramadan, and empower sufferers to have a dialog with their docs to make sure they’re totally protected.
AstraZeneca Kuwait Nation Director, Moustafa Abdelhady, stated: “There is no such thing as a doubt that non-communicable ailments like diabetes have to be managed, significantly given the excessive price of prevalence in Kuwait. One essential manner of doing that is by means of training, and that is the goal of our ‘Past Sugar’ marketing campaign. We hope to convey consideration to the truth that controlling blood sugar ranges is just not the one think about managing T2DM. It’s also the persistence of sustaining the objective of avoiding problems secondary to T2DM within the close to and distant future. We hope to name appreciable consideration to the gravity of the illness and methods to overcome the medical issues that include it, and we can not do that with out the suitable companions in place. We’re very grateful to the Kuwait Diabetes Society, Kuwait Nephrology Affiliation, Kuwait Society of Endocrinology and Kuwait Medical Affiliation for his or her help and becoming a member of us on this essential initiative to coach residents residing with or with out diabetes.”
Head of the Diabetes Unit at Mubarak Alkabeer Hospital and President of Kuwait Diabetes Society, Dr. Waleed Al Dahi stated: “Kuwait Diabetes Society is eager to help affected person consciousness initiatives, and this 12 months we’re happy to companion with AstraZeneca to launch the Past Sugar initiative to make sure protected fasting within the holy month of Ramadan. Affected person consciousness and training are paramount, and with this initiative, we hope to fight any misconceptions about T2DM, together with how the illness is just not solely linked to excessive sugar ranges however may influence important organs corresponding to the center and kidneys.”
AstraZeneca’s consciousness marketing campaign will characteristic a collection of brief movies that can improve public consciousness of how diabetes goes ‘Past Sugar’, together with explaining what T2D is and the way T2D makes individuals weak to unseen and hidden problems of cardiovascular and renal illness. The data within the movies are offered by key healthcare professionals in Kuwait together with, the Head of the Diabetes Unit at Mubarak Alkabeer Hospital and President of Kuwait Diabetes Society, Dr. Waleed Al Dahi, the Head of the Nephrology Unit at Al Amiri Hospital and Vice President of Kuwait Nephrology Affiliation, Dr. Anas Alyousif, the Head of the Kuwaiti Society of Endocrinology and Guide Endocrinology and Diabetologist at Jahra Hospital, Dr. Sameer Alshemari, and a Guide Diabetologist from Mouwasat Hospital, Dr. Habib Steitieh.
‘Past Sugar’ is a world venture that can pilot in Kuwait earlier than its implementation throughout the GCC. Beginning in April, the general public marketing campaign will run for 4 weeks in the course of the holy month of Ramadan throughout the societies’ and AstraZeneca’s GCC social media accounts and AstraZeneca’s affected person software, HealthGate.
AstraZeneca (AZ) is a British-Swedish multinational pharmaceutical and biotechnology firm specializing in medicines and pipelines for Diabetes, Cardiovascular, Renal, Oncology, Respiratory and Immunology remedy areas. In Kuwait, the corporate works hand-in-hand with the Ministry of Well being to create a supportive ecosystem that improves affected person experiences and outcomes, and collaborates with Kuwait’s Sufferers Serving to Fund Society.
© Press Launch 2021